SEC Form 5 · accession 0001437749-17-002478
Sun BioPharma, Inc. · SNBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael T. Cullen
Officer — Executive Chairman · Director · 10% Owner
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029125
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2016 | G | 15,000 | $0.00 | D | 1,605,000 | D | |
| Common Stock | Dec 21, 2016 | G | 15,000 | $0.00 | D | 1,590,000 | D | |
| Common Stock | Dec 21, 2016 | G | 15,000 | $0.00 | D | 1,575,000 | D | |
| Common Stock | holding | — | — | — | 1,895,764 | I | By Cullen Living Trust Dated April 23, 2009 |
Table II — derivative securities
No Table II lines on this filing.